"US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction"@en . . "11"^^ . "2"^^ . . . "RIV/00023001:_____/09:00002039" . . "RIV/00023001:_____/09:00002039!RIV10-MZ0-00023001" . "The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction" . . . . "000266346300007" . "336862" . "The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction" . "The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction"@en . "European journal of heart failure" . "Clark, A. L." . "L\u00E1nsk\u00E1, V\u011Bra" . . "[A27299D538AA]" . "4" . . "V" . "N-terminal pro--B-type natriuretic peptide; prognosis; chronic heart failure; treatment monitoring; community-based heart failure programme"@en . . "Kub\u00E1nek, Milo\u0161" . . "Decreased N-terminal pro-B-type natriuretic peptide (NT-proBNP) during treatment of chronic heart failure (CHF) is associated with improved prognosis. However, there is lack of data from community-based HF programmes. We hypothesized that plasma levels of NT-proBNP, measured after optimization of pharmacotherapy in patients with CHF, may provide independent prognostic information when compared with baseline values and conventional prognostic markers."@en . "11" . "5"^^ . "Cleland, JGF." . . . . . "Goode, KM" . "Decreased N-terminal pro-B-type natriuretic peptide (NT-proBNP) during treatment of chronic heart failure (CHF) is associated with improved prognosis. However, there is lack of data from community-based HF programmes. We hypothesized that plasma levels of NT-proBNP, measured after optimization of pharmacotherapy in patients with CHF, may provide independent prognostic information when compared with baseline values and conventional prognostic markers." . "1388-9842" . . .